Protocol · Liver & Digestive Health
Hepatic Encephalopathy Support Protocol
L-Carnitine (LOLA alternative) and Branched-Chain Amino Acids (BCAAs) are the core of this stack, with 5 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Hepatic Encephalopathy Support.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
7 supplements · 2 graded · 1 graded A
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file | Shop |
|---|---|---|---|---|---|
| Primary stackThe core of this protocol | |||||
| L-Carnitine (LOLA alternative) | Amount listed: 1–2 g L-carnitine daily or 9–18 g LOLA daily | Enhances ammonia detoxification and provides neuroprotection; L-ornithine L-aspartate (LOLA) is the standard form studied for HE
| Grade A for Ammonia5 studies · 387 people | ||
| Branched-Chain Amino Acids (BCAAs) | Amount listed: 0.25 g/kg/day or as directed | Compete with aromatic amino acids for brain uptake; may improve mental status and protein tolerance | Not graded yet | ||
| Supporting stackListed as additions to the core | |||||
| Zinc | Amount listed: 50–150 mg daily (as zinc sulfate) | Cofactor for urea cycle enzymes; deficiency common in cirrhosis; supplementation may reduce ammonia levels | Not graded yet | ||
| Probiotics | Amount listed: Multi-strain formula, 10–50 billion CFU daily | Reduce ammonia-producing gut bacteria; decrease intestinal ammonia absorption and systemic inflammation | Not graded yet | ||
| Resveratrol | Amount listed: 150–500 mg daily | Neuroprotective antioxidant; may reduce oxidative stress and inflammation in hepatic encephalopathy
| Grade B for Blood Urea Nitrogen (BUN)894 people | ||
| Vitamin D | Amount listed: 2,000–4,000 IU daily (based on levels) | Deficiency extremely common in liver disease; associated with worse outcomes; supplementation may support brain function | Not graded yet | ||
| Omega-3 Fatty Acids | Amount listed: 1–2 g EPA+DHA daily | Anti-inflammatory effects may reduce systemic inflammation contributing to encephalopathy | Not graded yet | ||
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Hepatic Encephalopathy. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The 2 supplements in this protocol graded A or B. Each opens third-party tested products, matched to the dose above where we can.
- Grade A
- Grade B
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
How this protocol works
In plain language
Hepatic encephalopathy (HE) is a brain dysfunction caused by liver disease. When the liver can't properly detoxify blood, toxins—especially ammonia—build up and affect brain function. Symptoms range from subtle cognitive changes (minimal HE) to confusion, personality changes, sleep disturbances, and in severe cases, coma. HE typically occurs in people with cirrhosis, especially after a precipitating event like infection, GI bleeding, constipation, or medication changes.
CRITICAL: Hepatic encephalopathy requires medical management. Standard treatment includes lactulose and/or rifaximin to reduce ammonia. This protocol is ADJUNCTIVE to standard therapy, not a replacement. Acute HE requires immediate medical attention.
- L-Ornithine L-Aspartate (LOLA) is the most studied supplement for HE. It provides substrates for ammonia detoxification—ornithine activates urea cycle enzymes, while aspartate provides a carbon skeleton for glutamine synthesis. Meta-analyses show LOLA significantly reduces ammonia levels and improves mental status. Standard L-carnitine may provide some similar benefits through enhanced energy metabolism and neuroprotection.
- Branched-Chain Amino Acids (BCAAs) help correct the amino acid imbalance seen in liver disease. Normally, BCAAs and aromatic amino acids (AAAs) compete for brain entry. In liver disease, AAA levels rise, increasing neurotoxic substances in the brain. BCAA supplementation helps restore this balance and may improve mental function.
- Zinc is a cofactor for two key urea cycle enzymes that convert ammonia to urea. Zinc deficiency is extremely common in cirrhosis (due to poor absorption, increased losses, and dietary restrictions). Supplementation can help reduce ammonia levels and may improve HE.
- Probiotics target the gut—a major source of ammonia from bacterial metabolism of protein. They can reduce ammonia-producing bacteria, strengthen the gut barrier (reducing bacterial translocation), and decrease systemic inflammation. Studies show probiotics can prevent and treat HE.
- Resveratrol is a powerful antioxidant that may protect brain cells from the oxidative stress caused by ammonia and other toxins. It also has anti-inflammatory effects that may help reduce the systemic inflammation that contributes to HE.
- Vitamin D deficiency is nearly universal in cirrhosis and is associated with worse liver disease outcomes. Vitamin D affects brain function through multiple mechanisms. Correcting deficiency may support overall health and potentially cognitive function.
- Omega-3 Fatty Acids have anti-inflammatory effects that may help reduce the systemic inflammation contributing to HE. They may also support brain membrane function.
Expected timeline: LOLA effects: within days to weeks for acute episodes. Zinc: 2-4 weeks to correct deficiency. Probiotics: 2-4 weeks for gut effects. These supplements support standard HE therapy and ongoing liver disease management.